Lymphangiographic evaluation of patients with clinical lepromatous leprosy on clofazimine.
Identifieur interne : 005580 ( PubMed/Curation ); précédent : 005579; suivant : 005581Lymphangiographic evaluation of patients with clinical lepromatous leprosy on clofazimine.
Auteurs : S T Oommen [Inde] ; M V Natu ; M K Mahajan ; R S KadyanSource :
- International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [ 0148-916X ] ; 1994.
Descripteurs français
- KwdFr :
- MESH :
- effets indésirables : Clofazimine.
- imagerie diagnostique : Lymphoedème.
- traitement médicamenteux : Lèpre lépromateuse.
- Adolescent, Adulte, Adulte d'âge moyen, Humains, Lymphoedème, Lymphographie.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Clofazimine.
- chemically induced : Lymphedema.
- diagnostic imaging : Lymphedema.
- drug therapy : Leprosy, Lepromatous.
- Adolescent, Adult, Humans, Lymphography, Middle Aged.
Abstract
Pedal edema as a possible adverse effect of clofazimine therapy in leprosy was first reported in 1990. Raasch, et al. reported their lymphangiographic findings on ten patients who had clinical lepromatous leprosy in 1969. None of these patients had been on clofazimine therapy. Our study, therefore, was designed to assess the changes that might be seen in the lymphatic system of patients treated with clofazimine for the management of leprosy. Our findings are compared with those of Raasch and his colleagues.
PubMed: 8189086
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :005580
Links to Exploration step
pubmed:8189086Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphangiographic evaluation of patients with clinical lepromatous leprosy on clofazimine.</title>
<author><name sortKey="Oommen, S T" sort="Oommen, S T" uniqKey="Oommen S" first="S T" last="Oommen">S T Oommen</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacology, Christian Medical College, Ludhiana, Punjab, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmacology, Christian Medical College, Ludhiana, Punjab</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Natu, M V" sort="Natu, M V" uniqKey="Natu M" first="M V" last="Natu">M V Natu</name>
</author>
<author><name sortKey="Mahajan, M K" sort="Mahajan, M K" uniqKey="Mahajan M" first="M K" last="Mahajan">M K Mahajan</name>
</author>
<author><name sortKey="Kadyan, R S" sort="Kadyan, R S" uniqKey="Kadyan R" first="R S" last="Kadyan">R S Kadyan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:8189086</idno>
<idno type="pmid">8189086</idno>
<idno type="wicri:Area/PubMed/Corpus">005580</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005580</idno>
<idno type="wicri:Area/PubMed/Curation">005580</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005580</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphangiographic evaluation of patients with clinical lepromatous leprosy on clofazimine.</title>
<author><name sortKey="Oommen, S T" sort="Oommen, S T" uniqKey="Oommen S" first="S T" last="Oommen">S T Oommen</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacology, Christian Medical College, Ludhiana, Punjab, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmacology, Christian Medical College, Ludhiana, Punjab</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Natu, M V" sort="Natu, M V" uniqKey="Natu M" first="M V" last="Natu">M V Natu</name>
</author>
<author><name sortKey="Mahajan, M K" sort="Mahajan, M K" uniqKey="Mahajan M" first="M K" last="Mahajan">M K Mahajan</name>
</author>
<author><name sortKey="Kadyan, R S" sort="Kadyan, R S" uniqKey="Kadyan R" first="R S" last="Kadyan">R S Kadyan</name>
</author>
</analytic>
<series><title level="j">International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association</title>
<idno type="ISSN">0148-916X</idno>
<imprint><date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Clofazimine (adverse effects)</term>
<term>Humans</term>
<term>Leprosy, Lepromatous (drug therapy)</term>
<term>Lymphedema (chemically induced)</term>
<term>Lymphedema (diagnostic imaging)</term>
<term>Lymphography</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Clofazimine (effets indésirables)</term>
<term>Humains</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (imagerie diagnostique)</term>
<term>Lymphographie</term>
<term>Lèpre lépromateuse (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Clofazimine</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Leprosy, Lepromatous</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Clofazimine</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lèpre lépromateuse</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Humans</term>
<term>Lymphography</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Lymphographie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Pedal edema as a possible adverse effect of clofazimine therapy in leprosy was first reported in 1990. Raasch, et al. reported their lymphangiographic findings on ten patients who had clinical lepromatous leprosy in 1969. None of these patients had been on clofazimine therapy. Our study, therefore, was designed to assess the changes that might be seen in the lymphatic system of patients treated with clofazimine for the management of leprosy. Our findings are compared with those of Raasch and his colleagues.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8189086</PMID>
<DateCreated><Year>1994</Year>
<Month>06</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted><Year>1994</Year>
<Month>06</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>11</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0148-916X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>62</Volume>
<Issue>1</Issue>
<PubDate><Year>1994</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association</Title>
<ISOAbbreviation>Int. J. Lepr. Other Mycobact. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Lymphangiographic evaluation of patients with clinical lepromatous leprosy on clofazimine.</ArticleTitle>
<Pagination><MedlinePgn>32-6</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Pedal edema as a possible adverse effect of clofazimine therapy in leprosy was first reported in 1990. Raasch, et al. reported their lymphangiographic findings on ten patients who had clinical lepromatous leprosy in 1969. None of these patients had been on clofazimine therapy. Our study, therefore, was designed to assess the changes that might be seen in the lymphatic system of patients treated with clofazimine for the management of leprosy. Our findings are compared with those of Raasch and his colleagues.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oommen</LastName>
<ForeName>S T</ForeName>
<Initials>ST</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology, Christian Medical College, Ludhiana, Punjab, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Natu</LastName>
<ForeName>M V</ForeName>
<Initials>MV</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mahajan</LastName>
<ForeName>M K</ForeName>
<Initials>MK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kadyan</LastName>
<ForeName>R S</ForeName>
<Initials>RS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Int J Lepr Other Mycobact Dis</MedlineTA>
<NlmUniqueID>8505819</NlmUniqueID>
<ISSNLinking>0148-916X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>D959AE5USF</RegistryNumber>
<NameOfSubstance UI="D002991">Clofazimine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002991" MajorTopicYN="N">Clofazimine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015440" MajorTopicYN="N">Leprosy, Lepromatous</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008220" MajorTopicYN="N">Lymphography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year>
<Month>3</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1994</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1994</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">8189086</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005580 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 005580 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:8189086 |texte= Lymphangiographic evaluation of patients with clinical lepromatous leprosy on clofazimine. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:8189086" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |